Quoin Pharmaceuticals, Ltd.
QNRX
$7.20
-$0.0796-1.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 10.08% | 18.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.14% | 64.53% | |||
| Operating Income | 4.14% | -64.53% | |||
| Income Before Tax | 3.05% | -64.94% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.05% | -64.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.05% | -64.94% | |||
| EBIT | 4.14% | -64.53% | |||
| EBITDA | 4.17% | -65.21% | |||
| EPS Basic | 3.35% | 47.42% | |||
| Normalized Basic EPS | 3.35% | 47.42% | |||
| EPS Diluted | 3.10% | 47.61% | |||
| Normalized Diluted EPS | 3.35% | 47.42% | |||
| Average Basic Shares Outstanding | 0.32% | 213.70% | |||
| Average Diluted Shares Outstanding | 0.60% | 215.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||